在一般化肌痛性硬化症患者的最小表现或更好的状态下,严重性指标的切断值是最小的
Genya Watanabe1, Yoshiki Takai2, Yuriko Nagane3
1Department of Neurology, National Hospital Organization Sendai Medical Center, Sendai, Japan.
Frontiers in immunology
|January 7, 2025
概括
本研究提出了客观的标准,用于最小的表现或更好的 (MM-或更好的) 状态在严重肌痛性肌痛症 (MG). 像MG-ADL,QMG和MGC分数这样的定量指标可以帮助在临床实践和试验中更精确地定义MM或更好的状态.
科学领域:
- 神经学 神经学
- 临床研究 临床研究
- 患者的治疗结果.
背景情况:
- 目前的肌痛性骨髓灰质炎 (MG) 治疗目标包括实现最小的表现或更好的 (MM或更好的) 状态.
- 对MM或更好的状态的主观评估导致临床实践和试验的模两可.
- 需要客观的标准来定义MM-或更好的状态在一般化MG患者.
研究的目的:
- 分析大量MG患者中的严重性指标.
- 提出定义MM或更好的状态的定量标准.
- 评估这些拟议标准的临床实用性.
主要方法:
- 利用了日本全国调查中3800名MG患者的数据.
- 在MM或更好和改善或更差组之间比较严重程度指标 (MG-ADL,QMG,MGC) (n=2784个通用MG患者).
- 严格的MM或更好的状态和相比较的临床特征的计算截止值.
主要成果:
- 对于严格的MM或更好的建议截止值:MG-ADL ≤2,QMG ≤7,MGC ≤4.
- 这些切断值在对患者进行分类时表现出高度的灵敏度,特异性和准确性.
- 严格的MM或更好的组报告了显著更好的生活质量 (修订的15项MG-QOL尺度).
结论:
- 对于MM或更好的状态的定量标准可以减少MG评估中的模两可.
- 这些客观指标对于严格的临床试验是有价值的.
- 建议的标准可以在临床环境中作为管理MG的参考.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
517
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
517
Myasthenia Gravis: Overview and Treatment
930
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
930
Disorders of the Skeletal Muscle
822
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
822
Chemical Synapses
8.5K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.5K


